Vivek Reddy, MD
The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, Icahn School of Medicine at Mount Sinai
Director of Cardiac Arrhythmia Service, The Mount Sinai Hospital
Director of Cardiac Electrophysiology, The Mount Sinai Health System
Vivek Y. Reddy, MD is Director of Electrophysiology for the Mount Sinai Health System, and The Helmsley Trust Professor of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai.
Dr. Reddy received his undergraduate and medical degrees from the University of Michigan. He completed his Internal Medicine Residency at Yale-New Haven Hospital, Cardiology Fellowship at the University of Chicago Hospitals, and Cardiac Electrophysiology Fellowship at Massachusetts General Hospital. In 2000, he then joined as an Electrophysiology Attending at Massachusetts General Hospital, during which time he also served as the Director of the Experimental Electrophysiology Laboratory at Massachusetts General Hospital. In 2008, he became the Director of the Cardiac Arrhythmia Service at the University of Miami Miller School of Medicine. Finally, in 2009, he moved to New York City to his current position at the Mount Sinai School of Medicine as a Professor of Medicine and Director of the Cardiac Arrhythmia Service. He was further appointed at the Director of Cardiac Electrophysiology of The Mount Sinai Health System in 2018. Dr. Reddy also serves as a Visiting Professor of Cardiology at Homolka Hospital in Prague, Czech Republic, where he has had an appointment since 2001.
Dr. Reddy is one of the nation’s premier cardiac electrophysiologists. He leads a team developing advanced therapies for cardiac arrhythmias and heart failure including catheter ablation for atrial fibrillation (the most common abnormal heart rhythm affecting millions of Americans) and ventricular tachycardia (the most common cause of sudden cardiac death), and device therapies for stroke prevention. Dr. Reddy’s initial research efforts included the role of imaging modalities (such as MRI and CT) to guide cardiac electrophysiology procedures. He led a team that developed, and in 2003, performed the first image-guided-therapy procedures in cardiac electrophysiology – that is, using pre-acquired 3-dimensional CT/MR images of the heart to guide catheter ablation of atrial fibrillation. His team specializes in cutting-edge clinical and translational research and have conducted many “first-in-human” studies of novel technologies including the first use of a balloon cryoablation catheter to treat patients with atrial fibrillation in 2004, and the first use of an endoscopic laser balloon catheter to visually guide ablation of atrial fibrillation in patients. Most recently, he performed the first AF catheter ablation procedures in the world using a novel non-thermal ablation energy – pulsed field ablation. He was also lead author on a seminal study, SMASH-VT (published in the New England Journal of Medicine) on the use of prophylactic catheter ablation to prevent shocks in patients receiving defibrillators. In 2012, he implanted the world’s first miniature leadless pacemaker, as well as the first leadless pacemaker in the United States at The Mount Sinai Hospital. And in 2021, he implanted the world’s first dual-chamber leadless pacemaker system – currently in the midst of a pivotal clinical trial. He has also been instrumental in the development of catheter-based mechanical approaches for stroke prevention in AF (instead of oral anticoagulant medications): he has been (or is) the principal investigator (or on the Steering Committees) of a number of such multicenter clinical trials including PROTECT-AF, PREVAIL, ASAP, ASAP-TOO, PRAGUE-17, OPTION, CATALYST, CHAMPION-AF, CAPTURE, CAPTURE2 and INTERCEPT.
Dr. Reddy is a highly sought-after speaker at major national and international conferences. He has directed or co-directed multiple international conferences, including serving as a co-Director since 2005 of the Annual Boston Atrial Fibrillation Symposium (widely acknowledged as the premier symposium on AF), founding and co-Directing since 2006 the Annual International Symposium on Ventricular Arrhythmias (widely acknowledged as the premier symposium on VT), and founding and co-Directing since 2015 the Annual pre-HRS Symposium on Stroke Prevention in Atrial Fibrillation. And most recently, starting in April 2021, he (along with Dr. Frank Marchlinski of the University of Pennsylvania) founded the ongoing VirtualEPConnect web-series (which has a viewership exceeding 5,000 individuals).